Related Experiment Video
Updated: Dec 11, 2025
High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
Published on: October 30, 2021
siRNA Design to Silence the 3'UTR Region of Zika Virus
María Perez-Mendez1, Paola Zárate-Segura1, Juan Salas-Benito2
1Laboratorio de Medicina Traslacional, Escuela Superior de Medicina, Instituto Politécnico Nacional, St. Salvador Díaz Mirón Esquina Plan de San Luis, Santo Tomas, Miguel Hidalgo, CDMX 11340, Mexico.
Abstract:
The disease caused by the Zika virus (ZIKV) has positioned itself as one of the main public health problems in Mexico. One of the main reasons is it causes microcephaly and other birth defects. The transmission of ZIKV is through Aedes aegypti and Ae. albopictus mosquitoes, which are found in a larger space of the national territory. In addition, it can also be transmitted via blood transfusion, sexual relations, and maternal-fetal route. So far, there are no vaccines or specific treatments to deal with this infection. Currently, some new therapeutics such as small interfering RNAs (siRNAs) are able to regulate or suppress transcription in viruses. Therefore, in this project, an in silico siRNA was designed for the 3'UTR region of ZIKV via bioinformatics tools. The designed siRNA was synthesized and transfected into the C6/36 cell line, previously infected with ZIKV in order to assess the ability of the siRNA to inhibit viral replication. The designed siRNA was able to inhibit significantly (p < 0.05) ZIKV replication; this siRNA could be considered a potential therapeutic towards the disease that causes ZIKV and the medical problems generated.
Insights
A novel small interfering RNA (siRNA) effectively inhibited Zika virus (ZIKV) replication in cell cultures. This bioinformatics-designed siRNA offers a promising therapeutic strategy against ZIKV infection and its associated birth defects.
Area of Science:
- Virology
- Molecular Biology
- Bioinformatics
Background:
- Zika virus (ZIKV) poses a significant public health threat, causing microcephaly and other birth defects.
- ZIKV is transmitted by *Aedes* mosquitoes and through other routes, with no current vaccines or specific treatments.
- Small interfering RNAs (siRNAs) show potential for regulating viral transcription and replication.
Purpose of the Study:
- To design an *in silico* siRNA targeting the 3'UTR region of ZIKV.
- To evaluate the efficacy of the designed siRNA in inhibiting ZIKV replication in cell culture.
Main Methods:
- Bioinformatic tools were used to design a specific siRNA against the ZIKV 3'UTR.
- The synthesized siRNA was transfected into ZIKV-infected C6/36 cells.
- Viral replication was assessed to determine siRNA efficacy.
Main Results:
- The designed siRNA significantly inhibited ZIKV replication (p < 0.05).
- The *in silico*-designed siRNA demonstrated potent antiviral activity.
Conclusions:
- The developed siRNA is a potential therapeutic candidate for ZIKV infection.
- This approach highlights the utility of bioinformatics in developing novel antiviral strategies.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:15Experimental RNAi